Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Houston, Texas 77030


Purpose:

The objective of this study is to evaluate the efficacy and safety of ALC in the treatment of non-anemic, breast cancer subjects who develop moderate or severe fatigue during adjuvant radiotherapy.


Study summary:

The objective of this study is to evaluate the efficacy and safety of ALC in the treatment of non-anemic, breast cancer subjects who develop moderate or severe fatigue during adjuvant radiotherapy


Criteria:

Inclusion Criteria: - Stage 0-III breast cancer in which adjuvant radiation is indicated; - Qualifying Brief Fatigue Inventory (BFI) score 6. - Exclusion Criteria: - Medication to treat or manage fatigue and pain - Use of erythropoietin to control anemia - Clinical evidence of hypothyroidism or hyperthyroidism


NCT ID:

NCT00555841


Primary Contact:

Principal Investigator
Carmen Escalante, MD
The University of Texas MD Anderson Cancer Center


Backup Contact:

N/A


Location Contact:

Houston, Texas 77030
United States



There is no listed contact information for this specific location.

Site Status: N/A


Data Source: ClinicalTrials.gov

Date Processed: August 17, 2017

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.


Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.